The cefpodoxime proxetil market continued to move with a strong uptrend during December 2025. This rise has been supported by the reduced supply of active pharmaceutical ingredients, which has been impacted by increased costs of production, along with other logistics. Additionally, the increased costs of freight and energy have supported the higher demand, resulting in the continued rise of the cefpodoxime proxetil market. On the demand side, the winter season saw a rise in cases of bacterial infections, which in turn increased prescriptions of cefpodoxime proxetil. This augured well for the distribution of cefpodoxime proxetil, as a significant number of hospitals, clinics, and medical stores increased their procurement of cefpodoxime proxetil. For the future, it is projected that cefpodoxime proxetil will continue to have a tight market in the first quarter of 2026, allowing it to retain its high prices. Although the demand during the other seasons will ease later on, the ongoing need for medical care and the conservative approach in inventories are expected to ensure market stability without sudden corrections in prices.
